专家们就HER2检测方法的价值展开辩论。 - Suppr

Suppr

超能文献

Experts debate value of HER2 testing methods.

作者信息

Nelson N J

出版信息

J Natl Cancer Inst. 2000 Feb 16;92(4):292-4. doi: 10.1093/jnci/92.4.292.

DOI:10.1093/jnci/92.4.292

PMID:10675369

Abstract

摘要

相似文献

Experts debate value of HER2 testing methods.

J Natl Cancer Inst. 2000 Feb 16;92(4):292-4. doi: 10.1093/jnci/92.4.292.

Accuracy and precision in HER2/neu testing in breast cancer: are we there yet?

Hum Pathol. 2004 Feb;35(2):143-6. doi: 10.1016/j.humpath.2004.01.002.

How do you tell whether a breast cancer is HER2 positive? Ongoing studies keep debate in high gear.

J Natl Cancer Inst. 2011 Jan 19;103(2):87-9. doi: 10.1093/jnci/djq557. Epub 2010 Dec 29.

HER2 testing recommendations in Australia.

Pathology. 2001 Nov;33(4):425-7. doi: 10.1080/00313020120083133.

Inconsistency of HER2 test raises questions.

J Natl Cancer Inst. 2007 Jul 18;99(14):1064-5. doi: 10.1093/jnci/djm075. Epub 2007 Jul 10.

Human epidermal growth factor receptor 2 testing recommendation.

Arch Pathol Lab Med. 2007 Sep;131(9):1330-1; author reply 1331-3. doi: 10.5858/2007-131-1330b-HEGFRT.

HER2--a discussion of testing approaches in the USA.

Ann Oncol. 2001;12 Suppl 1:S101-7. doi: 10.1093/annonc/12.suppl_1.s101.

Re: HER2 testing in the real world.

J Natl Cancer Inst. 2003 Apr 16;95(8):628; author reply 628-9. doi: 10.1093/jnci/95.8.628.

[HER2 testing in breast cancer].

Nihon Rinsho. 2007 Jun 28;65 Suppl 6:275-80.

Trastuzumab administration associated with change in HER2 status.

Clin Breast Cancer. 2008 Aug;8(4):366-9. doi: 10.3816/CBC.2008.n.044.

引用本文的文献

Synthesis and evaluation of near-infrared (NIR) dye-herceptin conjugates as photoacoustic computed tomography (PCT) probes for HER2 expression in breast cancer.

Bioconjug Chem. 2008 Jun;19(6):1186-93. doi: 10.1021/bc700482u. Epub 2008 May 28.

Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2.

Drugs. 2002;62(1):209-43. doi: 10.2165/00003495-200262010-00008.

The role of fluorescence in situ hybridization technologies in molecular diagnostics and disease management.

Mol Diagn. 2000 Dec;5(4):309-19. doi: 10.1007/BF03262092.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Experts debate value of HER2 testing methods.

J Natl Cancer Inst. 2000 Feb 16;92(4):292-4. doi: 10.1093/jnci/92.4.292.

Accuracy and precision in HER2/neu testing in breast cancer: are we there yet?

Hum Pathol. 2004 Feb;35(2):143-6. doi: 10.1016/j.humpath.2004.01.002.

How do you tell whether a breast cancer is HER2 positive? Ongoing studies keep debate in high gear.

J Natl Cancer Inst. 2011 Jan 19;103(2):87-9. doi: 10.1093/jnci/djq557. Epub 2010 Dec 29.

HER2 testing recommendations in Australia.

Pathology. 2001 Nov;33(4):425-7. doi: 10.1080/00313020120083133.

Inconsistency of HER2 test raises questions.

J Natl Cancer Inst. 2007 Jul 18;99(14):1064-5. doi: 10.1093/jnci/djm075. Epub 2007 Jul 10.

Human epidermal growth factor receptor 2 testing recommendation.

Arch Pathol Lab Med. 2007 Sep;131(9):1330-1; author reply 1331-3. doi: 10.5858/2007-131-1330b-HEGFRT.

HER2--a discussion of testing approaches in the USA.

Ann Oncol. 2001;12 Suppl 1:S101-7. doi: 10.1093/annonc/12.suppl_1.s101.

Re: HER2 testing in the real world.

J Natl Cancer Inst. 2003 Apr 16;95(8):628; author reply 628-9. doi: 10.1093/jnci/95.8.628.

[HER2 testing in breast cancer].

Nihon Rinsho. 2007 Jun 28;65 Suppl 6:275-80.

Trastuzumab administration associated with change in HER2 status.

Clin Breast Cancer. 2008 Aug;8(4):366-9. doi: 10.3816/CBC.2008.n.044.

引用本文的文献

Synthesis and evaluation of near-infrared (NIR) dye-herceptin conjugates as photoacoustic computed tomography (PCT) probes for HER2 expression in breast cancer.

Bioconjug Chem. 2008 Jun;19(6):1186-93. doi: 10.1021/bc700482u. Epub 2008 May 28.

Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2.

Drugs. 2002;62(1):209-43. doi: 10.2165/00003495-200262010-00008.

The role of fluorescence in situ hybridization technologies in molecular diagnostics and disease management.

Mol Diagn. 2000 Dec;5(4):309-19. doi: 10.1007/BF03262092.